To shed light on this complex subject, MPR interviewed Joshua D Brown, PharmD, PhD, Assistant Professor, Pharmaceutical Outcomes & Policy.
Your search for Warfarin returned 6 results
Familial hypercholesterolemia (FH), an inherited genetic disorder characterized by significantly elevated low-density lipoprotein cholesterol (LDL-C) levels, affects an estimated 620,000 Americans and is generally underdiagnosed and undertreated.
The FDA decision that 23andMe’s Saliva Collection Kit and Personal Genome Service (PGS) should be classified as a medical device was highly controversial. Two experts weigh in on this complex issue.
Cardiac drug interactions make up almost 25% of all preventable adverse drug reactions.
The incidence of inflammatory bowel disease has been rising, although the reasons for this increase are unclear. Several environmental factors may be responsible, although smoking is the only established environmental risk factor.
When the Human Genome Project was completed in 2001, it was anticipated that by 2020 the pharmacogenomics approach for predicting drug responsiveness would become standard practice.